Editors' ChoiceCancer Immunology

Paper of note in Science Translational Medicine 9 (381)

See allHide authors and affiliations

Science Signaling  21 Mar 2017:
Vol. 10, Issue 471, eaan2470
DOI: 10.1126/scisignal.aan2470

This week’s article describes a therapy that may enable macrophages to recognize and kill tumor cells in pediatric patients with brain cancer.


Brain tumors, meet macrophages

Gholamin et al. show that an engineered antibody against CD47 blocks a “don’t eat me” signal on pediatric brain tumor cells to enable macrophages to attack the tumor in mouse models.

Highlighted Article

Stay Connected to Science Signaling

Navigate This Article